We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
The European Centre for Disease Prevention and Control (ECDC) reports 2 cases of dengue in the south of France. The cases are resident of Gardanne, near Marseille in the Bouches-du-Rhone depoartment.
Neither person had travelled abroad and they are thought to have been infected in the local area. Mosquito control activities are underway.
Dengue is an infection found in tropical and sub-tropical climates worldwide. It has occurred in France in recent years. Dengue is spread by Aedes mosquito bites and can cause a severe flu-like illness.
All travellers to endemic regions are potentially at risk of dengue fever and should be aware of this infection.
Aedes mosquitoes are particularly persistent and aggressive. They bite between dawn and dusk.
A new dengue vaccine Qdenga® has been licensed in the UK and is awaiting JCVI recommendations for use.
Travellers developing a fever during or on return from travel are advised to seek medical attention as soon as possible.
For further information see TRAVAX dengue fever page.
